Cardiovascular risks associated with the use of low-dosed combined oral contraceptives;Kardiovaskuläre risiken unter der mikropille

Therapeutische Umschau

Volumn 58, Issue 9, 2001, Pages 564-569

  Merki Feld, G S ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DESOGESTREL; ETONOGESTREL; GESTAGEN; LEVONORGESTREL; LOW DOSE ORAL CONTRACEPTIVE; LYNESTRENOL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DOSE RESPONSE; DRUG SAFETY; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; INTRAUTERINE CONTRACEPTIVE DEVICE; MIGRAINE; ORAL CONTRACEPTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0034855794     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.58.9.564     Document Type: Review

References (29)

1. World Health Organization Scientific Group on cardiovascular disease and steroid hormone contraception: report of a World Health Organization Scientific Group. World Health Organization technical report series: 877. Geneva, Switzerland: World Health Organization, 1998.
2. Engel HJ, Engel E, Lichtlen PR. Coronary atherosclerosis and myocardial infarction in young women - role of oral contraceptives. Eur Heart J 1983; 1: 1-6.
3. Clarkson TB, Shively CA, Morgan TM, Koritnik DR, Adams-MR, Kaplan JR. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys. Obstet Gynecol 1990; 75: 217-22.
4. Adams MR, Anthony MS, Manning JM, Golden DG, Parks JS. Low-dose contraceptive estrogen-progestin and coronary artery atherosclerosis of monkeys. Obstet Gynecol 2000; 96: 250-5.
5. Beral V, Hermon C, Kay C, Hannaford P, Darby S, Reeves G. Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study. BMJ 1999; 318: 96-100.
6. Merki Feld GS, Keller PJ. Decrease in endothelin-1 plasma levels during the menstrual cycle and after ethinylestradiol treatment [letter], Ann Intern Med 1999; 131: 394.
7. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-7.
8. Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, MacRae KD. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ 1996; 312: 83-8.
9. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582-8.
10. Bloemenkamp KW, Rosendaal FR, Heimerhorst FM, Buller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346: 1593-6.
11. Vessey MP, Lawless M, Yeates D. Oral contraceptives and stroke: findings in a large prospective study. Br Med J Clin Res Ed 1984; 289: 530-1.
12. Lidegaard O. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. BMJ 1993; 306: 956-63.
13. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet 1996; 348: 505-10.
14. Schwartz SM, Siscovick DS, Longstreth WT Jr; Psaty BM, Beverly RK, Raghunathan TE et al. Use of low-dose oral contraceptives and stroke in young women. Ann Intern Med 1997; 127: 596-603.
15. Tzourio C, Tehindrazanarivelo A, Iglesias S, Alperovitch A, Chedru F et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995; 310: 830-3.
16. Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. BMJ 1999; 318: 13-8.
17. Lidegaard O. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. Br J Obstet Gynaecol 1995; 102: 153-9.
18. Oleckno WA. The risk of stroke in young adults: an analysis of the contribution of cigarette smoking and alcohol consumption. Public-Health 1988; 102: 45-55.
19. Carolei A, Marini C, De Matteis G. History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet 1996; 347: 1503-6.
20. Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel HK. Stroke in users of low-dose oral contraceptives. N Engl J Med 1996; 335: 8-15.
21. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet 1996; 348: 498-505.
22. Heinemann LA, Lewis MA, Thorogood M, Spitzer WO, Guggenmoos-Holzmann I; Bruppacher R. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women. BMJ 1997; 315: 1502-4.
23. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med 1988; 319: 1313-7.
24. Croft P, Hannaford P Risk factors for acute myocardial infarction in women (letter). BMJ 1989; 298: 674.
25. Rosenberg L, Palmer JR, Lesko SM, Shapiro-S. Oral contraceptive use and the risk of myocardial infarction. Am J Epidemiol 1990; 13: 1009-16.
26. Thorogood M, Mann J, Murphy M, Vessey M. Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case-control study Br J Obstet Gynaecol 1991; 98: 1245-53.
27. Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health ofYoung Women. Contraception 1997; 56: 129-40.
28. Dunn N, Thorogood M, Faragher B, et al. Oral contraceptives and myocardial infarction: results of the MICA case-control study. BMJ 1999; 318: 1579-83.
29. International Federation of Fertility Societies. Consensus Conference on Combination Oral Contraceptives and Cardiovascular disease. Fertil Steril 1999; 71: 1-6.